Checking carpal tunnel surgery patients for heart amyloidosis
Tests carpal tunnel surgery patients for transthyretin amyloidosis, then follows positive cases.
Plain-language title generated from the registry record
Registry title: ATTR Cardiac Amyloidosis in a Selected Population
Key facts
- Where
- Ålesund, NorwaySee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for older patients who have had carpal tunnel surgery at Ålesund Hospital. They will have a biopsy to check for ATTR amyloidosis and are followed for 10 years if it is found.
- Age
- Men over 50 years; women over 60 years.
- Sex
- Men and women can join, with different age limits.
- Disease stage
- Carpal tunnel syndrome that was operated on at Ålesund Hospital.
- Earlier treatment
- Must have had carpal tunnel surgery at Ålesund Hospital.
Main reasons for not taking part
- Has not given consent
- Does not speak Norwegian
- Carpal tunnel syndrome from another cause, such as injury or rheumatic disease
- Cannot be followed for more than 5 years because of other medical conditions
- Had heart disease at the time of the carpal tunnel operation
Read by machine on 12 November 2026.
Where in Norway
- Ålesund HospitalÅlesund, NorwayContact: Torstein Hole, PhDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Helse Møre og Romsdal HF
- Trial code
- NCT06458374
- Record updated
- 12 August 2026
- Original description
Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.Read full original descriptionShow less
Prevalence and Long Tem Follow up of ATTR Cardiac Amyloidosis in a Selected Population of Patients Operated on Carpal Tunnel Syndrome
Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.
Inclusion: Male > 50 years; Female > 60 years; operated CTS at Ålesund Hospital.
Exclusion: Cardiac disease at time of operation for CTS; cannot be followed > 5 years due to other medical conditions; not consented; do not speak Norwegian; secondary cause of CTS as traumatic or rheumatic.